Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Monk

Showing results (271-280 of 738) with videos related to

Pageof 74
Sort By:
Optics Express|March 5, 2024
Robust single-shot 3D fluorescence imaging in scattering media with a simulator-trained neural networkJeffrey Alido, Joseph Greene, Yujia Xue, et al.
Gynecologic Oncology|December 3, 2014
A cost-utility analysis of NRG Oncology/Gynecologic Oncology Group Protocol 218: incorporating prospectively collected quality-of-life scores in an economic model of treatment of ovarian cancerDavid E Cohn, Jason C Barnett, Lari Wenzel, et al.
Gynecologic Oncology|March 14, 2015
A Markov model to evaluate cost-effectiveness of antiangiogenesis therapy using bevacizumab in advanced cervical cancerLindsey E Minion, Jiaru Bai, Bradley J Monk, et al.
Bjpsych Open|September 24, 2024
Inequity in cardiometabolic hospital admissions and blood screening in New Zealand Indigenous Māori with psychosisNathan J Monk, Ruth Cunningham, James Stanley, et al.
Gynecologic Oncology|March 31, 2000
Development and assessment of a general theory of cervical carcinogenesis utilizing a severe combined immunodeficiency murine-human xenograft modelK S Tewari, J A Taylor, S Y Liao, et al.
Gynecologic Oncology|June 14, 2011
Circulating tumor cells predict progression free survival and overall survival in patients with relapsed/recurrent advanced ovarian cancerAndres Poveda, Stanley B Kaye, Robert McCormack, et al.
Gynecologic Oncology|December 14, 2011
Association of number of positive nodes and cervical stroma invasion with outcome of advanced endometrial cancer treated with chemotherapy or whole abdominal irradiation: a Gynecologic Oncology Group studyKrishnansu S Tewari, Virginia L Filiaci, Nick M Spirtos, et al.
Nature Medicine|September 23, 2003
Fc-dependent depletion of activated T cells occurs through CD40L-specific antibody rather than costimulation blockadeNicola J Monk, Roseanna E G Hargreaves, James E Marsh, et al.
Scientific Reports|May 16, 2019
Features of the cervicovaginal microenvironment drive cancer biomarker signatures in patients across cervical carcinogenesisPaweł Łaniewski, Haiyan Cui, Denise J Roe, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 22, 2026
Study outcome and journal impact factor: a meta-epidemiologic analysis of phase III gynecologic oncology trialsGabriel Levin, Emily Eiley, Lucy Gilbert, et al.
Pageof 74

Showing results (271-280 of 738) with videos related to

Sort By:
Pageof 74
Optics Express|March 5, 2024
Robust single-shot 3D fluorescence imaging in scattering media with a simulator-trained neural networkJeffrey Alido, Joseph Greene, Yujia Xue, et al.
Gynecologic Oncology|December 3, 2014
A cost-utility analysis of NRG Oncology/Gynecologic Oncology Group Protocol 218: incorporating prospectively collected quality-of-life scores in an economic model of treatment of ovarian cancerDavid E Cohn, Jason C Barnett, Lari Wenzel, et al.
Gynecologic Oncology|March 14, 2015
A Markov model to evaluate cost-effectiveness of antiangiogenesis therapy using bevacizumab in advanced cervical cancerLindsey E Minion, Jiaru Bai, Bradley J Monk, et al.
Bjpsych Open|September 24, 2024
Inequity in cardiometabolic hospital admissions and blood screening in New Zealand Indigenous Māori with psychosisNathan J Monk, Ruth Cunningham, James Stanley, et al.
Gynecologic Oncology|March 31, 2000
Development and assessment of a general theory of cervical carcinogenesis utilizing a severe combined immunodeficiency murine-human xenograft modelK S Tewari, J A Taylor, S Y Liao, et al.
Gynecologic Oncology|June 14, 2011
Circulating tumor cells predict progression free survival and overall survival in patients with relapsed/recurrent advanced ovarian cancerAndres Poveda, Stanley B Kaye, Robert McCormack, et al.
Gynecologic Oncology|December 14, 2011
Association of number of positive nodes and cervical stroma invasion with outcome of advanced endometrial cancer treated with chemotherapy or whole abdominal irradiation: a Gynecologic Oncology Group studyKrishnansu S Tewari, Virginia L Filiaci, Nick M Spirtos, et al.
Nature Medicine|September 23, 2003
Fc-dependent depletion of activated T cells occurs through CD40L-specific antibody rather than costimulation blockadeNicola J Monk, Roseanna E G Hargreaves, James E Marsh, et al.
Scientific Reports|May 16, 2019
Features of the cervicovaginal microenvironment drive cancer biomarker signatures in patients across cervical carcinogenesisPaweł Łaniewski, Haiyan Cui, Denise J Roe, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 22, 2026
Study outcome and journal impact factor: a meta-epidemiologic analysis of phase III gynecologic oncology trialsGabriel Levin, Emily Eiley, Lucy Gilbert, et al.
Pageof 74